Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

February 2026 (Vol. 46 Issue 2) Table of Contents
Anticancer Research: 46 (2)

Issue highlights

  • Coumarin-based Oximes Exert Monoamine Oxidase Inhibitory Activity
  • The miR-29b Byproduct MIRTX Shows Superior Anti-tumor Activity, Compared to miR-29b-3p, in Pancreatic Cancer Cells
  • Geographic Variations in Demographics, Socioeconomic Status, and Stage at Diagnosis Among Hormone Receptor–positive Invasive Ductal Carcinoma: An NCDB Analysis (2004-2020)
  • Describing the Mutational Characteristics of Myxofibrosarcoma: An AACR Project GENIE Analysis
  • Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer

 


 

New Special Issue on "​Ovarian Cancer Immunology and Immunotherapy– 2026"

Submission deadline: February 15, 2026;

Publication date: April 2026. ​

Click here for more information.

Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • You have access
    Targeting mTOR Signaling in Cancer: The Promise of Natural Product-derived Inhibitors
    PITHI CHANVORACHOTE, CHATCHAI CHAOTHAM, ZIN ZIN EI and PREEDAKORN CHUNHACHA
    Anticancer Research February 2026, 46 (2) 553-568; DOI: https://doi.org/10.21873/anticanres.17969
  • You have access
    Treatment Patterns and Prognostic Factors of Anti-HER2 Therapy in HER2-positive Advanced/Recurrent Gastric Cancer
    NORIKO WADA, YUKINORI KUROKAWA, TSUYOSHI TAKAHASHI, TAKURO SAITO, TAKAOMI HAGI, SHIGETO NAKAI, KOTA MOMOSE, KOTARO YAMASHITA, KOJI TANAKA, TOMOKI MAKINO, HIDETOSHI EGUCHI, YUICHIRO DOKI and TAROH SATOH
    Anticancer Research February 2026, 46 (2) 949-961; DOI: https://doi.org/10.21873/anticanres.18001
  • You have access
    Postmenopausal Stage IV Ovarian Yolk Sac Tumor With Neuroendocrine Features: Report of a Rare Case
    STEFANO FUCINA, LUCIA LERDA, MICHELE BARTOLETTI, ALESSANDRA PERIN, VINCENZO CANZONIERI and ANTONINO DITTO
    Anticancer Research February 2026, 46 (2) 1167-1172; DOI: https://doi.org/10.21873/anticanres.18019
  • You have access
    Targeted Sensitization of Leukemic T-cells to Anticancer Drugs by SIRT1 Agonist SRT-1720
    DONIKA IVANOVA, DESSISLAVA LAZAROVA, ZHIVKO ZHELEV, BILIANA NIKOLOVA, VASIL HADJIDEKOV, PLAMEN GETSOV and RUMIANA BAKALOVA
    Anticancer Research February 2026, 46 (2) 713-725; DOI: https://doi.org/10.21873/anticanres.17981
  • You have access
    Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab
    TAKAHITO AWATSU, TORU KADONO, HIROKAZU SHOJI, TOSHIHARU HIROSE, HIDEKAZU HIRANO, NATSUKO OKITA, ATSUO TAKASHIMA, AKIHITO NAGAHARA and KEN KATO
    Anticancer Research February 2026, 46 (2) 1021-1035; DOI: https://doi.org/10.21873/anticanres.18006
  • Open Access
    Clinical Parameters and Radiomics of Vestibular Schwannomas in NF2-related Schwannomatosis
    NINA BOE, VICTOR-F. MAUTNER, REINHARD E. FRIEDRICH, SAID C. FARSCHTSCHI, LASSE DÜHRSEN, HANNO S. MEYER and JOHANNES A. KOEPPEN
    Anticancer Research February 2026, 46 (2) 847-856; DOI: https://doi.org/10.21873/anticanres.17992
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire